Epithalon Protocol: The Sequence the Research Followed

The phrase Epithalon protocol returns amounts and intervals. In the setting the word borrows its authority from, a protocol is not a schedule at all: it is the advance specification of an experiment, written so that somebody else can run the same thing and see whether the same result comes out. Both meanings are in circulation, and only one of them has anything behind it.

What an Epithalon protocol means in each of the two places the word appears

In a laboratory, a protocol is a document that exists before any data does. It names the species, the strain, the sex and the age of the animals or the cell line and its passage number. It names the route, the vehicle, the concentration and the schedule. It names the control condition, states who is blinded to which group, and defines the outcome measure and the exact moment it will be read. It usually states the statistical plan too.

Every field on that list exists to close off an alternative explanation. The control condition closes off the possibility that the change would have happened anyway. Blinding closes off the assessor's expectations. Naming the outcome in advance closes off the option of examining the data first and then deciding which measurement to report.

On a vendor page, a protocol is a number and an interval. It has no author, no control condition, no outcome and no plan for deciding whether it worked. It borrows the word from the first document and none of the content.

The programme's own order of work, from tissue preparation to tetrapeptide

There is a genuine sequence here, and it is worth laying out because it is the part with substance in it.

The work began with the pineal gland and with a peptide preparation obtained from that tissue. That preparation is a mixture. Studies of it are studies of everything in it at once.

From there the programme moved to a defined synthetic tetrapeptide, Ala-Glu-Asp-Gly, which could be made to specification rather than extracted. That is the compound sold today. The move from an extract to a defined molecule is a normal progression, and it is also the point where the evidence quietly splits: results obtained with the mixture are not automatically results about the tetrapeptide, because a mixture contains other components and nobody can say from the mixture's data which one produced the effect.

The published work then extends across cell culture and rodent studies, and includes reports involving older people. The telomerase related claims sit largely in the cell culture layer. The ageing and lifespan claims sit largely in mice and rats. Almost all of it comes from Khavinson and colleagues in St Petersburg.

Why one group is a structural problem rather than an accusation

This is the fact that shapes everything else, so it is worth being careful about what it does and does not imply.

It does not imply dishonesty. Concentrated literatures are common and usually have dull explanations: a group develops the methods, holds the materials and the animal colonies, and keeps working on a question nobody else took up.

What it does imply is that the ordinary correction process has not run. Laboratories differ from each other in ways that only surface when a second one attempts the same experiment: reagent sources, animal strains and their housing, assay conditions, scoring conventions, the hundred small decisions that never make it into a methods section. Replication exposes those. A result that has only ever been produced in one building has not met any of them.

That is why a finding reported once by one group and a finding reproduced independently belong in different categories, even when the first one is entirely correct. The category is a statement about what has been tested, not about who did the work.

The difference between a schedule that can fail and one that cannot

There is a property a laboratory protocol has that a vendor schedule lacks entirely, and it explains why the online numbers never change.

A study specification states, before anything begins, what result would count as the effect and what result would count as its absence. It names the outcome, the moment it will be read, the comparison it will be read against and the threshold that decides. Those commitments make the study capable of failing. That is the point of them. A design that cannot produce a disappointing answer has not tested anything.

A circulating schedule commits to nothing of the kind. It states an amount and an interval and stops. There is no outcome, no comparison and no moment of judgement, so there is no way for it to turn out to have been wrong. Nothing can contradict it, which is exactly why the same figures have been reprinted unchanged for years while the underlying evidence has not moved at all.

This is the clearest practical test a reader can apply to any protocol they find, for this compound or any other. Look for the sentence that says how you would know it had not worked. In a research specification that sentence is present and specific. On a vendor page it is absent, and its absence is not an oversight. A schedule that could fail would sometimes have to be withdrawn.

The phase that has not happened: somebody else, somewhere else

Follow the normal sequence forward from where this programme sits and the next steps are obvious and absent.

An independent laboratory would obtain the compound from a source it did not control, run the central experiments to the original specification, and publish the outcome whichever way it fell. A second would do the same. Where results held, a sponsor would have a reason to open a registration programme, and trials would appear in a public registry with protocols posted before enrolment.

None of that has occurred. There are no registered interventional trials for this compound, which is why this page cites no trial identifier, and there is no marketing authorisation anywhere.

So the honest answer to what the protocol is, in the sense the searcher means, is that the document that would define it has not been written, because the studies it would define have not been run.

Questions about the research sequence